We first focused on ALDH1A1 expression, since we previously demonstrated that, in pediatric AML, ALDH1A1 gene RNA had a stronger association with risk group classification than the established biomarker CALCRL did [35]. The gene discussed is ALDH1A1; the disease is acute myeloid leukemia.